Key Takeaways
- • Bracebridge Capital has grown to $10.3 billion in assets from $5.8 billion four years ago, generating approximately 10% annualized returns since inception, making it the largest hedge fund globally run by a woman.
- • Yale University's endowment holds approximately $1 billion in Bracebridge, one of its most profitable investments, after an initial $50 million stake placed by David Swensen and Thomas Steyer in 1994.
- • Bracebridge's fixed-income arbitrage strategy exploited pricing differentials while maintaining exceptional risk discipline, delivering a 2% gain in 2015 when the hedge fund industry averaged 0.6% and major competitors suffered significant losses.
- • The fund experienced only eight losing months since 2009, outperforming prominent peers including Bill Ackman's Pershing Square (down 20.5% in 2015) and David Einhorn's Greenlight Capital (down 20.4%), which were hurt by significant market dislocations and poor stock selection.
Summary
Nancy Zimmerman's Bracebridge Capital has emerged as one of the most successful yet secretive hedge funds operating today, delivering exceptional risk-adjusted returns while remaining largely out of public view. According to Bloomberg, the Boston-based firm has expanded from $5.8 billion in assets four years prior to $10.3 billion as of early 2016, with a track record of approximately 10% annualized returns since its 1994 inception. This scale and performance profile makes Bracebridge the largest hedge fund in the world operated by a woman, a distinction that has been overshadowed by greater attention paid to Leda Braga's $9.5 billion Systematica Investments.
Yale University's endowment, managed by renowned investor David Swensen, has captured substantial value from an early bet on Zimmerman's strategy. Swensen and Thomas Steyer of Farallon Capital Management jointly staked Bracebridge with approximately $50 million when the fund launched in 1994. Yale's position has appreciated to approximately $1 billion, ranking among the endowment's most profitable holdings within its $25.6 billion portfolio. Swensen attributed the fund's success to Zimmerman's disciplined approach: "She's employing this leveraged strategy to exploit pricing differentials in the fixed-income world with an obsessive focus on risk."
The fund's 2015 performance vividly illustrates its competitive advantage. Bracebridge gained 2% while the broader hedge fund industry averaged a 0.6% return, navigating a turbulent year marked by the August Chinese currency devaluation, European government bond rallies, and sharp oil price declines. The fund has posted only eight losing months since 2009, demonstrating exceptional consistency. By contrast, prominent hedge fund managers struggled significantly: Bill Ackman's publicly traded Pershing Square Holdings declined 20.5%, damaged substantially by exposure to Valeant Pharmaceuticals, while David Einhorn's Greenlight Capital fell 20.4% amid poor stock selections, marking the fund's second losing year in its history.
Zimmerman's low-profile approach stands in contrast to the public-facing nature of many hedge fund leaders. Her career includes surviving a 1990s scandal involving Russia, her husband, and Harvard University, yet she has maintained focus on investment performance rather than public prominence. This discretion extends to Bracebridge's operations, contributing to the fund's characterization as secretive despite its substantial size and institutional backing.
Yale University's endowment, managed by renowned investor David Swensen, has captured substantial value from an early bet on Zimmerman's strategy. Swensen and Thomas Steyer of Farallon Capital Management jointly staked Bracebridge with approximately $50 million when the fund launched in 1994. Yale's position has appreciated to approximately $1 billion, ranking among the endowment's most profitable holdings within its $25.6 billion portfolio. Swensen attributed the fund's success to Zimmerman's disciplined approach: "She's employing this leveraged strategy to exploit pricing differentials in the fixed-income world with an obsessive focus on risk."
The fund's 2015 performance vividly illustrates its competitive advantage. Bracebridge gained 2% while the broader hedge fund industry averaged a 0.6% return, navigating a turbulent year marked by the August Chinese currency devaluation, European government bond rallies, and sharp oil price declines. The fund has posted only eight losing months since 2009, demonstrating exceptional consistency. By contrast, prominent hedge fund managers struggled significantly: Bill Ackman's publicly traded Pershing Square Holdings declined 20.5%, damaged substantially by exposure to Valeant Pharmaceuticals, while David Einhorn's Greenlight Capital fell 20.4% amid poor stock selections, marking the fund's second losing year in its history.
Zimmerman's low-profile approach stands in contrast to the public-facing nature of many hedge fund leaders. Her career includes surviving a 1990s scandal involving Russia, her husband, and Harvard University, yet she has maintained focus on investment performance rather than public prominence. This discretion extends to Bracebridge's operations, contributing to the fund's characterization as secretive despite its substantial size and institutional backing.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.